The effect of Farnesoid X Receptor agonism on the gut microbiome and mortality during cholestatic liver disease Open Access
Pahnke, Andrew (Spring 2023)
Abstract
Chronic liver diseases such as cholestatic liver diseases and non-alcoholic fatty liver disease are prevalent issues in today’s world. The last decade has witnessed an explosion of insights into the role of gut microbiota in cholestatic liver disease; however, much remains unknown. The liver begins the production of bile acids which break down fats in the diet. Cholestatic liver diseases tremendously alter the bile profile of the patient, but little is known about how this would affect the gut microbiota. Using a mouse model of cholestatic liver disease, multidrug resistance gene 2 knockout (Mdr2-/-) mice, we studied how a high-fat diet (HFD) alters gut microbiota and disease outcomes during cholestatic liver disease progression. Mdr2-/- mice were used because cholestatic liver disease is known to disrupt bile synthesis and transport in this mouse model. Bile acid synthesis can be activated by the Farnesoid X receptor (FXR) signaling pathway in mice. GW4064 is an agonist of the FXR pathway which influences the production of bile acids in mice. Our aim is to examine how the administration of GW4064 to Mdr2-/- mice will influence their bile profile and their gut microbiota. Gut commensal bacteria Lactobacillus colonization of the intestine indicates a healthy microbiome. Our data suggest that the addition of the GW4064 agonist had an adverse effect on mouse mortality and Lactobacillus colonization levels within the gut. This could be due to a negative impact of the FXR agonist on commensal bacteria counts which allowed for pathogenic proliferation; however, I am unable to make that claim as there were no visible changes in mRNA expression due to the GW4064 agonist.
Table of Contents
1. INTRODUCTION & AIMS
1. Primary Sclerosing Cholangitis
2. Gut Dysbiosis
3. Bile Acid Synthesis
Figure 1: Bile Acid Synthesis Pathways
4. Farnesoid X Receptor Regulation
Figure 2: Farnesoid X Receptor Signaling
5. Our Aims and Objectives
2. METHODS
Table 1: Experiment Layout
1. Animal Experiments
2. Standard Bacteriological Culture of Liver, Ileum, and Feces
3. Quantitative Polymerase Chain Reaction
4. Statistical Analysis
3. RESULTS
1. Mouse Mortality
Figure 3: Mortality of MDR2-/- Mice
2. Bacterial Colony Counts
Figure 4: Lactobacillus
Figure 5: Enteroccoccus
Figure 6: Unidentified Bacteria
3. mRNA Expression
Figure 7: FGF15 mRNA Expression
Figure 8: FXR and CYP7A1 mRNA Expression
4. DISCUSSION & FUTURE DIRECTIONS
5. REFERENCES
6. SUPPLEMENTAL TABLE
About this Honors Thesis
School | |
---|---|
Department | |
Degree | |
Submission | |
Language |
|
Research Field | |
Keyword | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
The effect of Farnesoid X Receptor agonism on the gut microbiome and mortality during cholestatic liver disease () | 2023-04-08 10:00:31 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|